MAIER PAUL V

Sr. V-P, CFO at LIGAND PHARMACEUTICALS INC · on record since Mar 14, 2006
Director at BTHC III INC. · on record since Jul 24, 2007
Director at PURE BIOSCIENCE · on record since Jan 24, 2008
Director at Hana Biosciences Inc · on record since Mar 21, 2008
Chief Financial Officer at SEQUENOM INC · on record since Apr 21, 2010
Director at NEXMED INC · on record since Jun 5, 2012
Director at TELIK INC · on record since Jul 17, 2014
Director at AIxCrypto Holdings, Inc. · on record since Jun 24, 2015
Director at Eton Pharmaceuticals, Inc. · on record since Nov 15, 2018
Director at Ambrx Biopharma Inc. · on record since Jan 31, 2023

Insider trading activity of MAIER PAUL V

Transactions on record: 371; since Nov 21, 2003

Open-market buys: 23; $78.8K

Open-market sells: 119; $2.5M

Companies traded: 11; last filing Aug 4, 2026

Figures computed from official regulatory filings — .

Companies where MAIER PAUL V has traded

Eton Pharmaceuticals, Inc.11 tx · $30K · Aug 4, 2026
BTHC III INC.73 tx · $388.7K · Jun 23, 2026
Ambrx Biopharma, Inc.3 tx · Mar 7, 2024
Ambrx Biopharma Inc.5 tx · Jun 9, 2023
AIxCrypto Holdings, Inc.5 tx · Jan 17, 2020
TELIK INC24 tx · $348.8K · Apr 4, 2018
11 tx · $10.9K · Jan 8, 2018
55 tx · $36K · Feb 12, 2014
16 tx · $5.3K · Jul 18, 2013
6 tx · $174.5K · Aug 2, 2012
162 tx · $4.3M · Nov 22, 2006

Track record of MAIER PAUL V

Statistical track record

Free

Open-market buys: 23

Last buy: Nov 15, 2018

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of MAIER PAUL V

Co-insiders of MAIER PAUL V

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Eton Pharmaceuticals, Inc.	Aug 4, 2026	AwardD (derivative)	10,000	0.00 USD	—	SEC
BTHC III INC.	Jun 23, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 23, 2026	AwardD (derivative)	182,584	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 14, 2026	AwardD (derivative)	12,196	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 14, 2026	AwardD (derivative)	7,757	0.00 USD	—	SEC
BTHC III INC.	Jun 20, 2025	AwardD (derivative)	532,786	0.00 USD	—	SEC
BTHC III INC.	Jun 20, 2025	AwardD (derivative)	30,000	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 6, 2025	AwardD (derivative)	25,000	0.00 USD	—	SEC
BTHC III INC.	Jun 13, 2024	AwardD (derivative)	361,111	0.00 USD	—	SEC
BTHC III INC.	Jun 13, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-15,000	—	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-30,000	—	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-12,142	—	—	SEC
Eton Pharmaceuticals, Inc.	Feb 15, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 16, 2023	AwardD (derivative)	445,205	0.00 USD	—	SEC
BTHC III INC.	Jun 16, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
Ambrx Biopharma Inc.	Jun 9, 2023	Award	85,000	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Mar 3, 2023	AwardD (derivative)	25,000	0.00 USD	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	AwardD (derivative)	105,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	OtherD (derivative)	-210,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	AwardD (derivative)	210,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	OtherD (derivative)	-105,000	—	—	SEC
BTHC III INC.	Jun 10, 2022	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 10, 2022	AwardD (derivative)	139,264	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Feb 28, 2022	AwardD (derivative)	50,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Eton Pharmaceuticals, Inc.	Aug 4, 2026	AwardD (derivative)	10,000	0.00 USD	—	SEC
BTHC III INC.	Jun 23, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 23, 2026	AwardD (derivative)	182,584	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 14, 2026	AwardD (derivative)	12,196	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 14, 2026	AwardD (derivative)	7,757	0.00 USD	—	SEC
BTHC III INC.	Jun 20, 2025	AwardD (derivative)	532,786	0.00 USD	—	SEC
BTHC III INC.	Jun 20, 2025	AwardD (derivative)	30,000	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Jan 6, 2025	AwardD (derivative)	25,000	0.00 USD	—	SEC
BTHC III INC.	Jun 13, 2024	AwardD (derivative)	361,111	0.00 USD	—	SEC
BTHC III INC.	Jun 13, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-15,000	—	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-30,000	—	—	SEC
Ambrx Biopharma, Inc.	Mar 7, 2024	OtherD (derivative)	-12,142	—	—	SEC
Eton Pharmaceuticals, Inc.	Feb 15, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 16, 2023	AwardD (derivative)	445,205	0.00 USD	—	SEC
BTHC III INC.	Jun 16, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
Ambrx Biopharma Inc.	Jun 9, 2023	Award	85,000	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Mar 3, 2023	AwardD (derivative)	25,000	0.00 USD	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	AwardD (derivative)	105,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	OtherD (derivative)	-210,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	AwardD (derivative)	210,000	—	—	SEC
Ambrx Biopharma Inc.	Jan 31, 2023	OtherD (derivative)	-105,000	—	—	SEC
BTHC III INC.	Jun 10, 2022	AwardD (derivative)	30,000	0.00 USD	—	SEC
BTHC III INC.	Jun 10, 2022	AwardD (derivative)	139,264	0.00 USD	—	SEC
Eton Pharmaceuticals, Inc.	Feb 28, 2022	AwardD (derivative)	50,000	0.00 USD	—	SEC